{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:09:35Z","timestamp":1787062175888,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jsps.2023.03.021","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T18:02:20Z","timestamp":1680717740000},"page":"1104-1108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Association between insulin resistance and abnormal menstrual cycle in Saudi females with polycystic ovary syndrome"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5532-131X","authenticated-orcid":false,"given":"Khulood","family":"Hussein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8943-0626","authenticated-orcid":false,"given":"Mohammed","family":"Karami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2023.03.021_b0005","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00404-020-05951-2","article-title":"Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update","volume":"303","author":"Abraham Gnanadass","year":"2021","journal-title":"Arch Gynecol Obstet."},{"key":"10.1016\/j.jsps.2023.03.021_b0010","unstructured":"Aldossary, K., Alotaibi, A., Alkhaldi, K., Alharbi, R., 2020. Prevalence of polycystic ovary syndrome, and relationship with obesity\/overweight: cross-sectional study in Saudi Arabia. J Adv Pharm Educ Res. 10,186\u2013190. E-ISSN: 2249-3379."},{"key":"10.1016\/j.jsps.2023.03.021_b0015","doi-asserted-by":"crossref","first-page":"E1967","DOI":"10.1210\/jc.2013-2815","article-title":"The Severity of Menstrual Dysfunction as a Predictor of Insulin Resistance in PCOS","volume":"98","author":"Brower","year":"2013","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsps.2023.03.021_b0020","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.fertnstert.2004.01.041","article-title":"Use of Fasting Blood to Assess the Prevalence of Insulin Resistance in Women With Polycystic Ovary Syndrome","volume":"82","author":"Carmina","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsps.2023.03.021_b0025","doi-asserted-by":"crossref","first-page":"96351","DOI":"10.18632\/oncotarget.19180","article-title":"The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis","volume":"8","author":"Ding","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.jsps.2023.03.021_b0030","first-page":"2538","article-title":"Ovarian Morphology and Serum Hormone Markers as Predictors of Ovarian Follicle Recruitment by Gonadotropins for In Vitro Fertilization","volume":"86","author":"Dumesic","year":"2001","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsps.2023.03.021_b0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.fertnstert.2013.02.011","article-title":"Ontogeny of the Ovary in Polycystic Ovary Syndrome","volume":"100","author":"Dumesic","year":"2013","journal-title":"Fertil Steril."},{"key":"10.1016\/j.jsps.2023.03.021_b0040","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.fertnstert.2020.12.015","article-title":"Menstrual Dysfunction in Polycystic Ovary Syndrome: Association With Dynamic State Insulin Resistance Rather Than Hyperandrogenism","volume":"115","author":"Ezeh","year":"2021","journal-title":"Fertil Steril."},{"key":"10.1016\/j.jsps.2023.03.021_b0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12958-021-00876-0","article-title":"Hyperandrogenism and Menstrual Imbalance are the Best Predictors of Metformin Response in PCOS Patients","volume":"20","author":"Garzia","year":"2022","journal-title":"Reprod Biol Endocrinol."},{"issue":"2014","key":"10.1016\/j.jsps.2023.03.021_b0050","article-title":"The role of androgen hormones in early follicular development","volume":"10","author":"Gerv\u00e1sio","year":"2014","journal-title":"ISRN Obstet Gynecol."},{"key":"10.1016\/j.jsps.2023.03.021_b0055","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ijc.30441","article-title":"Long and Irregular Menstrual Cycles, Polycystic Ovary Syndrome, and Ovarian Cancer Risk in a Population-Based Case-Control Study","volume":"140","author":"Harris","year":"2017","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.jsps.2023.03.021_b0060","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bpobgyn.2004.05.001","article-title":"Definitions, Prevalence and Symptoms of Polycystic Ovaries and Polycystic Ovary Syndrome","volume":"18","author":"Hart","year":"2004","journal-title":"Best. Pract. Res. Clin. Obstetrics Gynaecol."},{"key":"10.1016\/j.jsps.2023.03.021_b0065","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1055\/a-0992-9114","article-title":"Association between biomarkers of Low-grade inflammation and sex hormones in women with polycystic ovary syndrome","volume":"128","author":"Hatziagelaki","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"10.1016\/j.jsps.2023.03.021_b0070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1017\/S0954422416000287","article-title":"Metabolic Consequences of Obesity and Insulin Resistance in Polycystic Ovary Syndrome: Diagnostic and Methodological Challenges","volume":"30","author":"Jeanes","year":"2017","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.jsps.2023.03.021_b0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","article-title":"The Follicular Excess in Polycystic Ovaries, Due to Intra-Ovarian Hyperandrogenism, may be the Main Culprit for the Follicular Arrest","volume":"10","author":"Jonard","year":"2004","journal-title":"Hum. Reprod. Update."},{"key":"10.1016\/j.jsps.2023.03.021_b0080","doi-asserted-by":"crossref","unstructured":"Ka\u0142u\u017cna, M., Czlapka-Matyasik, M., Kompf, P., Moczko, J., Wachowiak-Ochmanska, K., Janicki, A., Samarzewska, K., Ruchala, M., Ziemnicka, K., 2022. Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome. Therapeutic Advances in Endocrinology and Metabolism. 13, 20420188211066699. doi:10.1177\/20420188211066699.","DOI":"10.1177\/20420188211066699"},{"key":"10.1016\/j.jsps.2023.03.021_b0085","article-title":"The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.jsps.2023.03.021_b0090","doi-asserted-by":"crossref","unstructured":"Louwers, Y.V., Laven, J.S.E., 2020. Characteristics of polycystic ovary syndrome throughout life. Ther Adv Reprod Health. 18,14:2633494120911038. doi: 10.1177\/2633494120911038.","DOI":"10.1177\/2633494120911038"},{"key":"10.1016\/j.jsps.2023.03.021_b0095","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis Model Assessment: Insulin Resistance and Beta-Cell Function From Fasting Plasma Glucose and Insulin Concentrations in Man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia."},{"key":"10.1016\/j.jsps.2023.03.021_b0100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.coemr.2020.03.004","article-title":"Polycystic ovary syndrome phenotypes and prevalence: Differential impact of diagnostic criteria and clinical versus unselected population","volume":"12","author":"Mumusoglu","year":"2020","journal-title":"Curr. Opin. Endocrinol. Metab. Res."},{"key":"10.1016\/j.jsps.2023.03.021_b0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40738-020-00094-z","article-title":"Evaluation of oocyte quality in Polycystic ovary syndrome patients undergoing ART cycles","volume":"7","author":"Nikbakht","year":"2021","journal-title":"Fertil Res Pract."},{"key":"10.1016\/j.jsps.2023.03.021_b0110","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tcm.2019.08.010","article-title":"Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention","volume":"30","author":"Osibogun","year":"2020","journal-title":"Trends Cardiovasc Med."},{"key":"10.1016\/j.jsps.2023.03.021_b0115","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.fertnstert.2021.04.018","article-title":"Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome","volume":"116","author":"Persson","year":"2021","journal-title":"Fertil Steril."},{"key":"10.1016\/j.jsps.2023.03.021_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40618-016-0523-8","article-title":"New markers of insulin resistance in polycystic ovary syndrome","volume":"40","author":"Polak","year":"2017","journal-title":"J Endocrinol Invest."},{"key":"10.1016\/j.jsps.2023.03.021_b0125","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tjog.2021.11.009","article-title":"Polycystic ovarian syndrome-current pharmacotherapy and clinical implications","volume":"61","author":"Rashid","year":"2022","journal-title":"Taiwanese J Obstet & Gynecol."},{"key":"10.1016\/j.jsps.2023.03.021_b0130","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group, 2004. Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS). Hum. Reprod. 19,41\u201347. doi: 10.1093\/humrep\/deh098.","DOI":"10.1093\/humrep\/deh098"},{"key":"10.1016\/j.jsps.2023.03.021_b0135","first-page":"e2027928","article-title":"Associations of Menstrual Cycle Characteristics Across the Reproductive Life Span and Lifestyle Factors with Risk of Type 2 Diabetes","volume":"3","author":"Wang","year":"2020","journal-title":"JAMANetw. Open."},{"key":"10.1016\/j.jsps.2023.03.021_b0140","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3390\/ijerph15112589","article-title":"Geographical prevalence of polycystic ovary syndrome as determined by region and race\/ethnicity","volume":"15","author":"Wolf","year":"2018","journal-title":"Int J Environ Res Public Health."},{"key":"10.1016\/j.jsps.2023.03.021_b0145","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0015-0282(03)01007-0","article-title":"Selective Ovary Resistance to Insulin Signaling in Women with Polycystic Ovary Syndrome","volume":"80","author":"Wu","year":"2003","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsps.2023.03.021_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.740377","article-title":"Association Between Menstrual Patterns and Adverse Pregnancy Outcomes in Patients With Polycystic Ovary Syndrome","volume":"12","author":"Yu","year":"2021","journal-title":"Front Endocrinol (Lausanne)."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016423000804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016423000804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T12:29:33Z","timestamp":1736166573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016423000804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1319016423000804"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2023.03.021","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between insulin resistance and abnormal menstrual cycle in Saudi females with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2023.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}